Edge Wealth Management LLC Clovis Oncology, Inc. Transaction History

Edge Wealth Management LLC

  • $475 Million
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Oct 21, 2020
SELL
$4.82 - $7.72 $6,025 - $9,650
-1,250 Closed
0 $0
Q2 2020

Aug 03, 2020
SELL
$5.69 - $9.69 $5,690 - $9,690
-1,000 Reduced 44.44%
1,250 $8,000
Q1 2020

Apr 20, 2020
BUY
$3.77 - $11.0 $7,540 - $22,000
2,000 Added 800.0%
2,250 $14,000
Q4 2019

Jan 29, 2020
BUY
$3.0 - $16.43 $750 - $4,107
250 New
250 $3,000

Others Institutions Holding CLVS

# of Institutions
1
Shares Held
166
Call Options Held
0
Put Options Held
0
View Full List

About Clovis Oncology, Inc.

CLVS Quotes by TradingView
  • Ticker CLVS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 144,480,000
  • Market Cap $13M
  • Description
  • Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...
More about CLVS
Track This Portfolio

Track Edge Wealth Management LLC Portfolio

Follow Edge Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Edge Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Edge Wealth Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email